Related Experiment Video
Updated: Jan 19, 2026

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
Published on: May 16, 2025
Primary Central Nervous System Burkitt Lymphoma in HIV Positive Pediatric Patient: A Rare Case Report
Priyanka A Patel1, Asha S Anand1, Sonia K Parikh1
1Department of Medical and Pediatric Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India.
Abstract:
Burkitt lymphoma is a high-grade B-cell lymphoma with aggressive course of disease and primarily systemic nodal involvement. Primary Burkitt lymphoma with isolated central nervous system (CNS) involvement and that too in pediatric population has been rarely reported. Here, we present a case of a primary Burkitt lymphoma involving brain in an human immunodeficiency virus-positive pediatric patient who was on antiretroviral therapy. Currently, there are no established protocols or guidelines for management of primary CNS Burkitt lymphoma thus posing challenges in the management of such cases. Our patient was successfully treated by surgical resection followed by chemotherapy and radiotherapy.
Related Concept Videos
05:09Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
06:46Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
08:28Targeted Metabolomics on Rare Primary Cells
11:28Culturing Microglia from the Neonatal and Adult Central Nervous System
10:02Whole-body PET/MRI of Pediatric Patients: The Details That Matter
05:28A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System

